Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy
August 28th, 2009
At any stage, lung cancer is a potentially systemic disease. Stage IIIA (N2) disease typifies this assertion. However, it encompasses a complex area characterised by much confusion and controversy, because data derived from a particular historical subgroup of IIIA (N2) often are inappropriately applied to another current subgroup. The basics of its treatment include the need for chemotherapy, preceding or following an effective loco-regional treatment. The choice of the optimal loco-regional treatment, however, is all the more debated that the present systemic treatment is still poor.
At 12:56 am on September 1st, 2009 Tony koay said:
very impressive writing. pls visit http://www.earthriese.net
At 1:20 pm on September 21st, 2009 Jan Bender said:
I feel the oncologist wasted my time , nearly killed me, wanted me to try one more time 3 other drs. said no Chemo., it would kill me. I had surgery that was enough. I ran out of that hospital. In Hospice now working full time.